These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27429119)

  • 1. Blood ghrelin, adiponectin and resistin levels during controlled ovarian stimulation in IVF cycles.
    Dafopoulos K; Messini CI; Anifandis G; Georgoulias P; Sourlas D; Messinis IE
    Physiol Res; 2016 Nov; 65(5):809-814. PubMed ID: 27429119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood ghrelin, resistin, and adiponectin concentrations during the normal menstrual cycle.
    Dafopoulos K; Sourlas D; Kallitsaris A; Pournaras S; Messinis IE
    Fertil Steril; 2009 Oct; 92(4):1389-1394. PubMed ID: 18829017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-selectin, resistin and reactive oxygen species levels in GnRH -agonist and -antagonist protocols in IVF/ICSI: a prospective cohort study.
    Siristatidis C; Askoxylaki M; Varounis C; Kassanos D; Chrelias C
    J Assist Reprod Genet; 2015 Jun; 32(6):959-67. PubMed ID: 25925352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between craving and ghrelin, adiponectin, and resistin levels in patients with alcoholism.
    Akkişi Kumsar N; Dilbaz N
    Alcohol Clin Exp Res; 2015 Apr; 39(4):702-9. PubMed ID: 25833030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
    Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles.
    Huang CC; Lien YR; Chen HF; Chen MJ; Shieh CJ; Yao YL; Chang CH; Chen SU; Yang YS
    Hum Reprod; 2012 Jul; 27(7):2036-45. PubMed ID: 22561057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study.
    Majuri A; Santaniemi M; Rautio K; Kunnari A; Vartiainen J; Ruokonen A; Kesäniemi YA; Tapanainen JS; Ukkola O; Morin-Papunen L
    Eur J Endocrinol; 2007 Feb; 156(2):263-9. PubMed ID: 17287417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of electro-acupuncture on clinical outcomes and ovarian hyperstimulation syndrome in in vitro fertilization and embryo transplantation].
    Hong YL; Tan Y; Yin YY; Zou YJ; Guo YH; Nie XW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Nov; 34(11):1292-6. PubMed ID: 25566616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acupuncture combined with medication improves endocrine hormone levels and ovarian reserve function in poor ovarian response patients undergoing in vitro fertilization-embryo transplantation].
    Dong XL; Ran JK; Zhang HJ; Chen K; Li HX
    Zhen Ci Yan Jiu; 2019 Aug; 44(8):599-604. PubMed ID: 31475495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin.
    Gonciarz M; Bielański W; Partyka R; Brzozowski T; Konturek PC; Eszyk J; Celiński K; Reiter RJ; Konturek SJ
    J Pineal Res; 2013 Mar; 54(2):154-61. PubMed ID: 22804755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there any interaction of resistin and adiponectin levels with protein-energy wasting among patients with chronic kidney disease.
    Kaynar K; Kural BV; Ulusoy S; Cansiz M; Akcan B; Misir N; Yaman S; Kaya N
    Hemodial Int; 2014 Jan; 18(1):153-62. PubMed ID: 23919731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality.
    Baldani DP; Skrgatic L; Kasum M; Zlopasa G; Kralik Oguic S; Herman M
    Gynecol Endocrinol; 2019 May; 35(5):401-405. PubMed ID: 30623695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced live-birth rates after IVF/ICSI in women with previous unilateral oophorectomy: results of a multicentre cohort study.
    Lind T; Holte J; Olofsson JI; Hadziosmanovic N; Gudmundsson J; Nedstrand E; Lood M; Berglund L; Rodriguez-Wallberg K
    Hum Reprod; 2018 Feb; 33(2):238-247. PubMed ID: 29211889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.